Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• T cell receptor (TCR) signal transduction modulation in CD8(+) T cells is a promising cancer immunotherapy strategy.
• Ras guanine nucleotide exchange factors (RasGRPs) regulate Ras activation threshold, impacting T cell responses.
• Diacylglycerol (DAG) influences RasGRP levels, and diacylglycerol kinase-ζ (DGKζ) metabolizes DAG, thereby regulating Ras signaling.

Purpose of the Study:

• To investigate if DGKζ-deficient CD8(+) T cells exhibit enhanced in vitro responses.
• To assess if targeting Ras activation thresholds can improve CD8(+) T cell responsiveness against tumors.
• To evaluate the role of DGKζ in regulating T cell activation and anti-tumor immunity.

Main Methods:

• Generating and analyzing DGKζ-deficient CD8(+) T cells.
• Assessing T cell activation thresholds using various TCR stimuli.
• Evaluating the in vitro and in vivo anti-tumor responses of DGKζ-deficient CD8(+) T cells.
• Analyzing Ras and ERK activation pathways.

Main Results:

• DGKζ-deficient CD8(+) T cells largely align with the current model of Ras activation.
• The EC(50) for TCR stimulation remained unchanged, indicating a complex role of DGKζ in Ras/ERK signaling.
• DGKζ-deficient CD8(+) T cells showed enhanced responsiveness in a subcutaneous lymphoma model.

Conclusions:

• DGKζ deficiency enhances CD8(+) T cell anti-tumor responsiveness.
• The analog-to-digital conversion threshold of T cell activation is a potential therapeutic target for cancer immunotherapy.
• Further research is warranted to fully elucidate the complex role of DGKζ in T cell signaling and anti-tumor immunity.